Arenz A, Klein M, Fiehe K. Occurrence of neurotoxic 4'-O-methylpyridoxine in
Ginkgo biloba
leaves, ginkgo medications and Japanese ginkgo food.
Planta Med.
1996;62:548 - 551.
Mizuno N, Kawakami K, Morita E. Competitive inhibition between 4'-substituted pyridoxine analogues and pyridoxal for pyridoxal kinase from mouse brain.
J Nutr Sci Vitaminol (Tokyo).
1980;26:535 - 543.
Wada K, Ishigaki S, Ueda K, et al. An antivitamin B6, 4'-methoxypyridoxine, from the seed of
Ginkgo biloba
L.
Chem Pharm Bull (Tokyo).
1985;33:3555 - 3557.
Yagi M, Wada K, Sakata M, et al. Studies on the constituents of edible and medicinal plants. IV. Determination of 4-O-methylpyridoxine in serum of the patient with gin-nan food poisoning [in Japanese; English abstract].
Yakugaku Zasshi.
1993;113:596 - 599.
Arenz A, Klein M, Fiehe K. Occurrence of neurotoxic 4'-O-methylpyridoxine in
Ginkgo biloba
leaves, ginkgo medications and Japanese ginkgo food.
Planta Med.
1996;62:548 - 551.
Monostory K, Vereczkey L, Levai F, et al. Ipriflavone as an inhibitor of human cytochrome P450 enzymes.
Br J Pharmacol.
1998;123:605 - 610.
Almeida JC, Grimsley EW. Coma from the health food store: interaction between kava and alprazolam.
Ann Intern Med.
1996;125:940 - 941.
Inoue F, Walsh RJ. Folate supplements and phenytoin-salicylate interaction.
Neurology.
1983;33:115 - 116.
Krause KH, Bonjour JP, Berlit P, et al. Biotin status of epileptics.
Ann N Y Acad Sci.
1985;447:297 - 313.
Said HM, Redha R, Nylander W. Biotin transport in the human intestine: inhibition by anticonvulsant drugs.
Am J Clin Nutr.
1989;49:127 - 131.
Kishi T, Fujita N, Eguchi T, et al. Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapy.
J Neurol Sci.
1997;145:109 - 112.
Reynolds EH. Mental effects of anticonvulsants, and folic acid metabolism.
Brain.
1968;91:197 - 214.
Hendel J, Dam M, Gram L, et al. The effects of carbamazepine and valproate on folate metabolism.
Acta Neurol Scand.
1984;69:226 - 231.
Berg MJ, Stumbo PJ, Chenard CA, et al. Folic acid improves phenytoin pharmacokinetics.
J Am Diet Assoc.
1995;95:352 - 356.
Lewis DP, Van Dyke DC, Willhite LA, et al. Phenytoin-folic acid interaction.
Ann Pharmacother.
1995;29:726 - 735.
Lewis DP, Van Dyke DC, Stumbo PJ, et al. Drug and environmental factors associated with adverse pregnancy outcomes. Part I: Antiepileptic drugs, contraceptives, smoking, and folate.
Ann Pharmacother.
1998;32:802 - 817.
Ono H, Sakamoto A, Eguchi T, et al. Plasma total homocysteine concentrations in epileptic patients taking anticonvulsants.
Metabolism.
1997;46:959 - 962.
Lewis DP, Van Dyke DC, Stumbo PJ, et al. Drug and environmental factors associated with adverse pregnancy outcomes. Part I: Antiepileptic drugs, contraceptives, smoking, and folate.
Ann Pharmacother.
1998;32:802 - 817.
Berg MJ, Stumbo PJ, Chenard CA, et al. Folic acid improves phenytoin pharmacokinetics.
J Am Diet Assoc.
1995;95:352 - 356.
Lewis DP, Van Dyke DC, Willhite LA, et al. Phenytoin-folic acid interaction.
Ann Pharmacother.
1995;29:726 - 735.
Kishi T, Fujita N, Eguchi T, et al. Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapy.
J Neurol Sci.
1997;145:109 - 112.
Berg MJ, Stumbo PJ, Chenard CA, et al. Folic acid improves phenytoin pharmacokinetics.
J Am Diet Assoc.
1995;95:352 - 356.
Lewis DP, Van Dyke DC, Stumbo PJ, et al. Drug and environmental factors associated with adverse pregnancy outcomes. Part I: Antiepileptic drugs, contraceptives, smoking, and folate.
Ann Pharmacother.
1998;32:802 - 817.
Wahl TO, Gobuty AH, Lukert BP. Long-term anticonvulsant therapy and intestinal calcium absorption.
Clin Pharmacol Ther. 1981;30:506 - 512.
Weinstein RS, Bryce GF, Sappington LJ, et al. Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment.
J Clin Endocrinol Metab.
1984;58:1003 - 1009.
Weinstein RS, Bryce GF, Sappington LJ, et al. Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment.
J Clin Endocrinol Metab.
1984;58:1003 - 1009.
Carter BL, Garnett WR, Pellock JM, et al. Effect of antacids on phenytoin bioavailability.
Ther Drug Monit.
1981;3:333 - 340.
McElnay JC, Uprichard G, Collier PS. The effect of activated dimethicone and a proprietary antacid preparation containing this agent on the absorption of phenytoin.
Br J Clin Pharmacol. 1982;13:501 - 505.
De Vivo DC, Bohan TP, Coulter DL, et al. L-carnitine supplementation in childhood epilepsy: current perspectives.
Epilepsia.
1998;39:1216 - 1225.
Coulter DL. Carnitine deficiency: a possible mechanism for valproate hepatotoxicity [letter].
Lancet.
1984;1:689.
Ater SB, et al. A developmental center population treated with VPA and L-carnitine. In: Update 1993: inborn errors of metabolism in the patient with epilepsy. Sigma-Tau Pharmaceuticals; 1993.
Dreifuss FE, Langer DH. Hepatic considerations in the use of antiepileptic drugs.
Epilepsia.
1987;28(suppl 2):S23 - S29.
Ater SB, et al. A developmental center population treated with VPA and L-carnitine. In: Update 1993: inborn errors of metabolism in the patient with epilepsy. Sigma-Tau Pharmaceuticals; 1993.
Freeman JM, Vining EP, Cost S, et al. Does carnitine administration improve the symptoms attributed to anticonvulsant medications? A double-blinded, crossover study.
Pediatrics.
1994;93:893 - 895.
De Vivo DC, Bohan TP, Coulter DL, et al. L-carnitine supplementation in childhood epilepsy: current perspectives.
Epilepsia.
1998;39:1216 - 1225.
Hahn TJ, Hendin BA, Scharp CR, et al. Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults.
N Engl J Med. 1972;287:900 - 904.
Hahn TJ, Hendin BA, Scharp CR, et al. Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults.
N Engl J Med. 1972;287:900 - 904.
Jubiz W, Haussler MR, McCain TA, et al. Plasma 1,25-dihydroxyvitamin D levels in patients receiving anticonvulsant drugs.
J Clin Endocrinol Metab.
1977;44:617 - 621.
Brodie MJ, Boobis AR, Dollery CT, et al. Rifampicin and vitamin D metabolism.
Clin Pharmacol Ther.
1980;27:810 - 814.
Williams C, Netzloff M, Folkerts L, et al. Vitamin D metabolism and anticonvulsant therapy: effect of sunshine on incidence of osteomalacia.
South Med J.
1984;77:834 - 836, 842.
Cornelissen M, Steegers-Theunissen R, Kollee L, et al. Increased incidence of neonatal vitamin K deficiency resulting from maternal anticonvulsant therapy.
Am J Obstet Gynecol.
1993;168:923 - 928.
Cornelissen M, Steegers-Theunissen R, Kollee L, et al. Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents neonatal vitamin K deficiency.
Am J Obstet Gynecol.
1993;168:884 - 888.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.